Showing results (261-270 of 372) with videos related to

Sort By:
Pageof 38
Lancet (London, England)|December 13, 2016
Treatment of infantile-onset spinal muscular atrophy with nusinersen: a phase 2, open-label, dose-escalation studyRichard S Finkel, Claudia A Chiriboga, Jiri Vajsar, et al.
The Lancet. Child & Adolescent Health|June 5, 2021
Treatment of infantile-onset spinal muscular atrophy with nusinersen: final report of a phase 2, open-label, multicentre, dose-escalation studyRichard S Finkel, Claudia A Chiriboga, Jiri Vajsar, et al.
Prehospital Emergency Care|October 25, 2000
A comparison of biphasic and monophasic shocks for external defibrillation. Physio-Control Biphasic InvestigatorsS L Higgins, J M Herre, A E Epstein, et al.
Human Molecular Genetics|July 4, 2019
Selective serotonin reuptake inhibitors ameliorate MEGF10 myopathyMadhurima Saha, Skylar A Rizzo, Manashwi Ramanathan, et al.
Pediatric Pulmonology|August 30, 2016
Treatment effect of idebenone on inspiratory function in patients with Duchenne muscular dystrophyGunnar M Buyse, Thomas Voit, Ulrike Schara, et al.
Journal of Clinical Medicine|May 11, 2024
Beyond Contractures in Spinal Muscular Atrophy: Identifying Lower-Limb Joint HypermobilityElizabeth R Harding, Cara H Kanner, Amy Pasternak, et al.
Muscle & Nerve|April 25, 2020
Spinal muscular atrophy care in the COVID-19 pandemic eraAravindhan Veerapandiyan, Anne M Connolly, Richard S Finkel, et al.
Muscle & Nerve|July 13, 2019
Nusinersen improves walking distance and reduces fatigue in later-onset spinal muscular atrophyJacqueline Montes, Sally Dunaway Young, Elena S Mazzone, et al.
Pageof 38